SIMPLEX TRADING, LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 277 filers reported holding SAGE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.64 and the average weighting 0.2%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$120
-100.0%
2,562
-85.2%
0.00%
-100.0%
Q2 2022$559,000
-22.9%
17,320
-21.0%
0.00%0.0%
Q1 2022$725,000
+194.7%
21,929
+279.2%
0.00%
Q4 2021$246,000
-66.2%
5,783
-54.4%
0.00%
-100.0%
Q3 2021$727,000
+1.1%
12,679
+0.1%
0.00%0.0%
Q2 2021$719,000
-72.9%
12,671
-64.3%
0.00%
-80.0%
Q1 2021$2,655,000
+727.1%
35,473
+853.1%
0.01%
Q4 2020$321,000
+386.4%
3,722
+239.9%
0.00%
Q3 2020$66,000
-78.6%
1,095
-89.8%
0.00%
-100.0%
Q1 2020$309,000
-39.3%
10,779
+196.8%
0.00%0.0%
Q3 2019$509,000
+25.4%
3,632
+63.8%
0.00%0.0%
Q2 2019$406,000
+15.3%
2,218
-11.2%
0.00%0.0%
Q3 2018$352,000
-38.5%
2,499
-31.6%
0.00%
-50.0%
Q2 2018$572,000
+1000.0%
3,655
+1031.6%
0.00%0.0%
Q1 2018$52,000
-72.8%
323
-72.2%
0.00%
-75.0%
Q4 2017$191,000
-86.0%
1,161
-94.7%
0.01%
-85.7%
Q3 2017$1,366,000
+85.3%
21,938
+137.0%
0.06%
+75.0%
Q2 2017$737,000
+622.5%
9,258
+540.2%
0.03%
+700.0%
Q1 2017$102,000
-20.3%
1,446
-42.7%
0.00%
-50.0%
Q4 2016$128,000
-6.6%
2,523
-15.4%
0.01%
-11.1%
Q3 2016$137,000
-83.7%
2,984
-89.3%
0.01%
-83.9%
Q2 2016$842,000
+308.7%
27,970
+471.9%
0.06%
+273.3%
Q3 2015$206,000
+8.4%
4,891
+87.7%
0.02%
-6.2%
Q2 2015$190,0002,6060.02%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,966,688$120,204,00010.81%
Integral Health Asset Management, LLC 230,000$14,058,0004.30%
Asymmetry Capital Management, L.P. 102,462$6,262,0004.02%
ACUTA CAPITAL PARTNERS, LLC 225,000$13,752,0003.74%
DAFNA Capital Management LLC 158,306$9,676,0003.14%
Bain Capital Life Sciences Investors, LLC 499,100$30,505,0002.84%
Boxer Capital, LLC 1,094,000$66,865,0002.31%
Palo Alto Investors LP 590,200$36,073,0001.98%
Logos Global Management LP 250,000$15,280,0001.96%
Bellevue Group AG 1,579,504$96,539,0001.33%
View complete list of SAGE THERAPEUTICS INC shareholders